$0.40
+0.02 (+6.29%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+5,362.8% upside
Low Target
$19.68
Average Target
$21.60
High Target
$29.43
Current Price
$0.40
Current
$0.40
$0.40
Target
$21.60
$21.60
$19.68
$21.60 avg
$29.43
Scenario Analysis
Bear Case
$19.68
4,877.2%
Low target
Base Case
$21.60
+5,362.8%
Avg target
Bull Case
$29.43
+7,343.1%
High target
Risk/Reward
1.5x
Balanced
Price in Context
52-Week High
$1.28
-69.1% from high
52-Week Low
$0.30
+31.8% from low
Target vs 52W High
$21.60
+1,587.5% vs high
Next Earnings Report
Nov 18, 2026
4d
until earnings
EPS Est: $-0.19
Earnings in 4 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.5% |
| AMGN | Hold | 42 | 43% | $190.87 | -59.1% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +115.9% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.2% |
| MRNA | Hold | 31 | 32% | $149.45 | -35.4% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -55.7% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -35.3% |